YOUNG Brits, under the age of 45, are up to 40 TIMES more likely to die of Covid than develop a brain blood clot after an AstraZeneca Jab, statistics show.
It comes as fears over the safety of the Oxford/AstraZeneca jab led 20 European countries to suspend vaccinations last month.
🦠 Read our coronavirus live blog for the latest news & updates…
Brits under the age of 45, are 40 TIMES more likely to die of Covid than develop a brain blood clot after an AstraZeneca JabCredit: LNP
But medics in Germany have said they have just seen just one case of CVST blood clots in every 90,000 people who get the jab – just 0.0012 per cent.
And last night the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced they have seen 30 cases of similar clots in 18.1million doses.
This is roughly one in one in every 600,000 people – or 0.0012 per cent.
Cambridge University academics say the risk of dying from coronavirus for 25- 44-year-olds is 0.04 per cent.
It is roughly 33 times higher than Germany’s CVST incidence rate.
Yesterday the AstraZeneca vaccine was once again ruled totally safe by the EU regulatorCredit: Rex
CVST is a serious condition which occurs when a blood clot forms in the brain’s venous sinuses.
This prevents blood from draining out of the brain and as a result, blood cells may break and leak into brain tissues, forming a haemorrhage.
This chain of events is part of a stroke, according to the John Hopkins University.
Experts say CVST affects about five people in one million each year, according to John Hopkins University.
And under-25s, who have a very low risk of death from Covid, are still four times more likely to die from the virus than to develop CVST after the jab.
Meanwhile, people aged 15-24 have a coronavirus death risk of just 0.005 per cent, making it four times more likely.
Yesterday the AstraZeneca vaccine was once again ruled totally safe by the EU regulator.
European Medicines Agency executive director Emer Cooke said there was “no evidence” that the AstraZeneca Covid vaccine should be restricted.
The EMA said that the benefits of the jab outweigh the risks.
The agency said: “A casual link [of blood clots] with the vaccine is not proven, but is possible and further analysis is continuing.”
Despite this statistics Chancellor Angela Merkel announced on Tuesday that Germany will restrict the use of AstraZeneca’s Covid vaccine to people aged 60 and over and high-priority groups.
The shock decision comes days after France, Italy and Germany resumed their rollout out of the AstraZeneca vaccine after the EU finally declared it safe.
The trio’s humiliating U-turn had come after all three countries led the way in suspending use of the jab amid an unfounded safety scare about the link with blood-clots.